HOTH•benzinga•
Hoth Therapeutics Announces Expanded Access Initiative For HT-001, Offering Critical Relief To Cancer Patients Facing Severe Skin Toxicities
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 11, 2025 by benzinga